Editas Medicine Q3 Net Loss Narrows
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…
Story updates
12:13:29 PM UTC
SquawkNews
Editas Medicine reported third-quarter 2026 revenue of $10.4 million and a net loss of $23.4 million, compared with revenue of $7.5 million and a net loss of $25.1 million a year earlier. The company received Australian ethics and regulatory clearance to begin its Phase 1/2 Strive study of EDIT-401…
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…